Search Filters
Advanced Search
SMC ID Date Medicine Submission Type Indication
820/12 10/12/2012 pazopanib (Votrient) Full For the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (STS) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo)adjuvant therapy.
676/11 07/03/2011 pazopanib (Votrient) Full For the first-line treatment of advanced renal cell carcinoma (RCC) and for patients who have received prior cytokine therapy for advanced disease

No medicines have been found.